Information on how to access Genotropin® (somatropin, rbe) prescribing information and adverse event reporting can be found at the bottom of the page.
Not all adolescent patients will need to continue GH therapy after reaching final height. However, some adult patients with growth hormone deficiency (GHD) may see benefits by continuing GH therapy beyond final height: 12
Continuing GH therapy after final height increases lean body mass and decreases fat mass 2-4
Continuing GH therapy induces a significant progression towards peak bone mass 5,6
Continuation of GH therapy beyond final height helps ensure that childhood-onset GHD patients achieve full somatic development 1-11
Children with GH deficiency should be treated as outlined in the NICE Technology Appraisal Guidance 188.13
When linear growth has been achieved with a growth rate < 2 cm/year, GH treatment should be stopped for 2–3 months, and then GH status should be re-assessed.
As outlined in the NICE Technology Appraisal Guidance TA6414 GH treatment at adult doses should be re-started only in those satisfying the biochemical criteria for severe GH deficiency (defined as a peak GH response of less than 9 mU/litre (3 ng/ml) during an insulin tolerance test or a cross-validated GH threshold in an equivalent test), and continued until adult peak bone mass has been achieved (normally around 25 years of age).
After adult peak bone mass has been achieved, the decision to continue growth hormone treatment should be based on all the specified criteria for adult growth hormone replacement therapy .
Pfizer offers a range of homecare and patient support services to Genotropin patients
Our dedicated nurse team are on hand to support patients being treated with Genotropin and healthcare professionals who have Genotropin patients
Contact the team
Genotropin (somatropin, rbe) 0.2mg Miniquick
Genotropin (somatropin, rbe) 0.4mg MiniQuick
Genotropin (somatropin, rbe) 0.6mg MiniQuick
Genotropin (somatropin, rbe) 0.8mg MiniQuick
Genotropin (somatropin, rbe) 1.2mg MiniQuick
Genotropin (somatropin, rbe) 1.4mg MiniQuick
Genotropin (somatropin, rbe) 1.6mg MiniQuick
Genotropin (somatropin, rbe) 1.8mg MiniQuick
Genotropin (somatropin, rbe) 12mg powder and solvent
Genotropin (somatropin, rbe) 1mg MiniQuick
Genotropin (somatropin, rbe) 2mg MiniQuick
Genotropin (somatropin, rbe) 5.3mg powder and solvent
Learn more about the 3 devices available for Genotropin patients
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020